{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:19:38Z","timestamp":1770441578218,"version":"3.49.0"},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":5395,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In order to determine the usefulness of anthralin in the treatment of psoriasis, we evaluated the effectiveness of topical anthralin therapy in patients with psoriasis vulgaris in our hospital. Seventy patients with plaque\u2010type psoriasis (58 men and 12 women), aged 17\u201379 years\u2010old (mean; 47.6 years\u2010old), who were treated at the Department of Dermatology, Tokyo Medical and Dental University, between 1992 and 1999, were retrospectively evaluated. Mean psoriasis activity and severity index (PASI) score before therapy was 24.6. Patients were treated with 0.1\u20132.0% topical anthralin. Responses were determined by clinical examination. The mean PASI score decreased to 8.7 after three months. The most effective anthralin concentration was 0.4\u20130.5%. The overall response rate was 85.7%, complete remission was obtained in 21.4%, and partial remission in 64.3%. Ten patients (14.3%) were anthralin\u2010resistant. In all patients who entered complete remission, recurrence was noted within six months after stopping anthralin. Minor skin irritation and pigmentation occurred in most of the patients; however, no severe side effects were noted during the treatment. Our study indicated that anthralin is effective for chronic plaque\u2010type psoriasis.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2000.tb02212.x","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T06:35:39Z","timestamp":1428647739000},"page":"482-485","source":"Crossref","is-referenced-by-count":10,"title":["Topical Anthralin for Psoriasis Vulgaris: Evaluation of 70 Japanese Patients"],"prefix":"10.1111","volume":"27","author":[{"given":"Toshiyuki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Dermatology Tokyo Medical and Dental University, School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Matsuuchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical and Dental University, School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Irimajiri","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical and Dental University, School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Otoyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical and Dental University, School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of Dermatology Tokyo Medical and Dental University, School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503023320907"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000210836"},{"key":"e_1_2_1_4_1","first-page":"79","article-title":"Dithranol, after 75 years still going strong","volume":"1","author":"Van de Kerkhof PCM","year":"1991","journal-title":"Eur J Dermatol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90820-1"},{"key":"e_1_2_1_6_1","first-page":"129","article-title":"Anthralin therapy for psoriasis: A retrospective study of 39 cases","volume":"99","author":"Higashi K","year":"1989","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02386.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12275369"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12274997"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12456188"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0026-895X(25)08662-6","article-title":"Structure\u2010activity relationship for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9\u2010anthrones","volume":"46","author":"Hayden PJ","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.4049\/jimmunol.156.11.4514","article-title":"Anti\u2010psoriatic drug anthralin activates transcription factor NF\u2010\u03baB in murine keratinocytes","volume":"156","author":"Schmidt KN","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499901"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1232.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70189-O"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb01018.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1984.tb00813.x"},{"key":"e_1_2_1_18_1","first-page":"125","article-title":"Irritation and staining by dithranol (anthralin) and related compounds: 1. Estimation with chamber testing and contact thermography","volume":"59","author":"Mustakallio KK","year":"1979","journal-title":"Acta Derm Venereol (Stockh) (suppl)"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91286-X"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2340\/0001555564174177","article-title":"Short contact anthralin therapy of psoriasis with and without UV\u2010irradiation and maintenance schedule to prevent relapses","volume":"64","author":"Brun P","year":"1984","journal-title":"Acta Derm Venereol (Stockh)"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2000.tb02212.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2000.tb02212.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:12:55Z","timestamp":1747887175000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2000.tb02212.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1111\/j.1346-8138.2000.tb02212.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2000.tb02212.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}